MX2018012671A - Combinacion, usos terapeuticos y usos profilacticos. - Google Patents

Combinacion, usos terapeuticos y usos profilacticos.

Info

Publication number
MX2018012671A
MX2018012671A MX2018012671A MX2018012671A MX2018012671A MX 2018012671 A MX2018012671 A MX 2018012671A MX 2018012671 A MX2018012671 A MX 2018012671A MX 2018012671 A MX2018012671 A MX 2018012671A MX 2018012671 A MX2018012671 A MX 2018012671A
Authority
MX
Mexico
Prior art keywords
combination
therapeutic
prophylactic
therapeutic uses
microbiome
Prior art date
Application number
MX2018012671A
Other languages
English (en)
Inventor
Mary Bragger Judith
Wayne Claycomb Rodney
Roger Ogle Colin
Original Assignee
Quantec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quantec Ltd filed Critical Quantec Ltd
Publication of MX2018012671A publication Critical patent/MX2018012671A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Esta invención se refiere al uso terapéutico y profiláctico de una combinación que incluye lactoperoxidasa y al menos otro componente, con un punto isoeléctrico de, o superior sustancialmente a 6.8, y los cuales se extraen de la leche, para modular el microbioma de un animal por selectividad contra al menos un microorganismo patógeno.
MX2018012671A 2016-04-21 2017-04-21 Combinacion, usos terapeuticos y usos profilacticos. MX2018012671A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ71927616 2016-04-21
PCT/NZ2017/050043 WO2017183996A1 (en) 2016-04-21 2017-04-21 Combination,therapeutic uses and prophylactic uses

Publications (1)

Publication Number Publication Date
MX2018012671A true MX2018012671A (es) 2019-03-07

Family

ID=60116237

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018012671A MX2018012671A (es) 2016-04-21 2017-04-21 Combinacion, usos terapeuticos y usos profilacticos.

Country Status (5)

Country Link
US (1) US12005100B2 (es)
EP (1) EP3445387A4 (es)
CN (1) CN109069593B (es)
MX (1) MX2018012671A (es)
WO (1) WO2017183996A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020017980A1 (en) * 2018-07-20 2020-01-23 Quantec Limited Ingestible formulation
CN114096851A (zh) * 2019-07-05 2022-02-25 昆泰克有限公司 用于定量样品中的多种蛋白质的方法
US20230405090A1 (en) * 2020-11-06 2023-12-21 Quantec Limited Antiviral agents
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85479A1 (fr) 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
CN101494970B (zh) * 2005-09-28 2012-09-26 文特里亚生物科学公司 用于肠道病症和/或补水的口服制剂
NZ547859A (en) * 2006-06-09 2009-05-31 Dec Int Nz Ltd Treatment method and composition for mastitis
TR201900010T4 (tr) * 2006-07-03 2019-02-21 Jean Paul Perraudin Hipohalit ve/veya hipotiyosiyanit içeren antimikrobiyal bileşimler ve bunların kullanımları.
CA2671507A1 (en) * 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutans streptococci
US20100028274A1 (en) 2007-02-28 2010-02-04 Morinaga Milk Industry Co., Ltd. Oral disinfectant, and food additive comprising the disinfectant
NZ600269A (en) * 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
US20120244226A1 (en) * 2009-12-15 2012-09-27 Dec International Nz Limited Treatment composition and method

Also Published As

Publication number Publication date
EP3445387A4 (en) 2019-12-11
EP3445387A1 (en) 2019-02-27
US12005100B2 (en) 2024-06-11
WO2017183996A1 (en) 2017-10-26
CN109069593B (zh) 2024-03-29
CN109069593A (zh) 2018-12-21
US20190134168A1 (en) 2019-05-09

Similar Documents

Publication Publication Date Title
EA201891970A1 (ru) Композиции, содержащие бактериальные штаммы
MX2021006456A (es) Composiciones que comprenden cepas bacterianas del genero megasphaera y sus usos.
BR112018010805A2 (pt) mutantes de proteína f de rsv
MY186296A (en) Novel promoter and use thereof
MA44890B1 (fr) Compositions comprenant des souches bactériennes
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
MA42471B1 (fr) Compositions comprenant des souches bactériennes
MX2022003906A (es) Aislado de proteina de maiz y metodos de manufacturacion del mismo.
MX2018012671A (es) Combinacion, usos terapeuticos y usos profilacticos.
MX2021008592A (es) Composiciones de trem y usos de las mismas.
BR112016016035A2 (pt) gene resistente à praga antropogênica, anticorpo de cadeia única de idiotípico de toxina anti-cry1ab codificado pelo mesmo e aplicação
WO2017165412A3 (en) T-cell exhaustion state-specific gene expression regulators and uses thereof
WO2018050143A3 (de) Vorrichtung zur zerstörung von pflanzen
WO2017112847A8 (en) Improved protein expression strains
MA48939A (fr) Compositions comprenant des souches bactériennes
MY190102A (en) Tolerogenic dna vaccine
EP3652130A4 (en) METHODS FOR CONTROLLING PATHOGENIC NEMATODES OF PLANTS AND IMPROVING THE HEALTH AND / OR PERFORMANCE OF RUMINANTS
GB2568440A (en) Modified factor H binding protein
TW201613489A (en) Hydrolyzed lactose-containing nutritional compositions and uses thereof
EA202090835A1 (ru) Композиции, содержащие бактериальные штаммы
MX2019001589A (es) Composiciones que comprenden manteca de cacao.
PH12016501179A1 (en) Composition
WO2016135462A8 (en) Treatment
Keener The dynamics of excitability
GB2566661A (en) Reduced fat spread